Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molidustat vs Darbepoetin Alfa in Non-dialysis CKD Anemia
NCT03350347Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of molidustat in anemia of chronic kidney disease (CKD-A), sponsored by Bayer. Started Dec 2017; status: completed.
02
Drugs
molidustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT03350347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03350347.